Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466745) titled 'Autus Valve Continued Access Study (CAS)' on March 5.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Autus Valve Technologies, Inc.

Condition: Congenital Heart Disease

Intervention: Device: Pulmonary Valve Replacement Surgery

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 15, 2026

Target Sample Size: 36

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07466745

Published by HT Digital Content Serv...